Not Tagged
merck,cel-sci
['head neck', 'scchn', 'celsci', '$mrk']
some great data from at #asco2022 after an extremely long p3 trial. statistically significant benefit in head neck/ oral cancer #scchn in the low risk population vs soc with a 4 year median os advantage. get this approved. #hnscc $cvm $mrk 